| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |